Cormac Sheridan[email protected]Molecular ImagingWMIC: Molecular imaging cries out for better toolsMultiscale imaging of the angiogenic network is uncovering new insights into tumor biology and challenging accepted anatomical models, but better tools -- both qualitative and validated -- are vital for multiparametric high-resolution mapping of structural, functional, cellular, and molecular imaging, according to a speaker at the World Molecular Imaging Congress (WMIC).September 12, 2012Molecular ImagingWMIC: Imaging remains 'poor relation' in research circlesDUBLIN - In funding terms, imaging research is still the poor relation and will remain so until there is more collaboration and the field acts in a concerted way to validate and standardize methods and technologies to support clinical translation, said a speaker at the World Molecular Imaging Congress (WMIC).September 9, 2012Molecular ImagingWMIC: Landscape changes for coronary artery disease casesDUBLIN - The management of patients with chronic coronary artery disease is moving rapidly from simple diagnosis to guidance of therapy and the prevention of future cardiac events, a Finnish researcher told delegates at the World Molecular Imaging Congress (WMIC).September 6, 2012Molecular ImagingWMIC: MRI-HIFU prepares to enter clinical arenaDUBLIN - The combination of MRI with high-intensity focused ultrasound (HIFU) results in a noninvasive technique that precisely targets finely controlled amounts of energy to defined locations and is gaining acceptance, delegates learned today at the World Molecular Imaging Congress (WMIC).September 4, 2012Page 1 of 1Top StoriesAdvanced VisualizationChatGPT promising as support tool for researchers getting started in AIChatGPT could serve as an academic reference tool for early-career radiologists and researchers.Advanced VisualizationLLMs outperform medical student in solving imaging casesClinical NewsIrish radiologist, 37, dies of cancerDigital X-RaySymphony of radiology: RSNA unveils art winnersIndustry NewsSiemens targets 3.3B patient touchpoints by 2030